Logo image of CHSR.PA

CHAUSSERIA (CHSR.PA) Stock Fundamental Analysis

EPA:CHSR - Euronext Paris - Matif - FR0000060907 - Common Stock - Currency: EUR

7  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CHSR. CHSR was compared to 43 industry peers in the Textiles, Apparel & Luxury Goods industry. No worries on liquidiy or solvency for CHSR as it has an excellent financial health rating, but there are worries on the profitability. CHSR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CHSR had positive earnings in the past year.
In the past year CHSR had a positive cash flow from operations.
Of the past 5 years CHSR 4 years were profitable.
In multiple years CHSR reported negative operating cash flow during the last 5 years.
CHSR.PA Yearly Net Income VS EBIT VS OCF VS FCFCHSR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500K -1M -1.5M

1.2 Ratios

CHSR's Return On Assets of 1.91% is on the low side compared to the rest of the industry. CHSR is outperformed by 65.12% of its industry peers.
CHSR's Return On Equity of 2.24% is on the low side compared to the rest of the industry. CHSR is outperformed by 67.44% of its industry peers.
Industry RankSector Rank
ROA 1.91%
ROE 2.24%
ROIC N/A
ROA(3y)5.46%
ROA(5y)-3.88%
ROE(3y)6.53%
ROE(5y)-5.07%
ROIC(3y)N/A
ROIC(5y)N/A
CHSR.PA Yearly ROA, ROE, ROICCHSR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

CHSR's Profit Margin of 5.30% is in line compared to the rest of the industry. CHSR outperforms 51.16% of its industry peers.
CHSR's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 48.85%, CHSR is not doing good in the industry: 74.42% of the companies in the same industry are doing better.
CHSR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 5.3%
GM 48.85%
OM growth 3YN/A
OM growth 5Y144.57%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.19%
GM growth 5Y3.5%
CHSR.PA Yearly Profit, Operating, Gross MarginsCHSR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60 -80

More info and screens

9

2. Health

2.1 Basic Checks

CHSR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHSR has about the same amount of shares outstanding.
CHSR has about the same amout of shares outstanding than it did 5 years ago.
There is no outstanding debt for CHSR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHSR.PA Yearly Shares OutstandingCHSR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K 400K
CHSR.PA Yearly Total Debt VS Total AssetsCHSR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

2.2 Solvency

CHSR has an Altman-Z score of 4.39. This indicates that CHSR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CHSR (4.39) is better than 76.74% of its industry peers.
CHSR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.39
ROIC/WACCN/A
WACC8.07%
CHSR.PA Yearly LT Debt VS Equity VS FCFCHSR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M

2.3 Liquidity

A Current Ratio of 16.39 indicates that CHSR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 16.39, CHSR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CHSR has a Quick Ratio of 13.59. This indicates that CHSR is financially healthy and has no problem in meeting its short term obligations.
CHSR has a Quick ratio of 13.59. This is amongst the best in the industry. CHSR outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 16.39
Quick Ratio 13.59
CHSR.PA Yearly Current Assets VS Current LiabilitesCHSR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

CHSR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -78.56%.
CHSR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.62%.
Measured over the past years, CHSR shows a very negative growth in Revenue. The Revenue has been decreasing by -13.48% on average per year.
EPS 1Y (TTM)-78.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-111.38%
Revenue 1Y (TTM)-15.62%
Revenue growth 3Y-1.92%
Revenue growth 5Y-13.48%
Sales Q2Q%-6.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSR.PA Yearly Revenue VS EstimatesCHSR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CHSR is valuated quite expensively with a Price/Earnings ratio of 30.43.
60.47% of the companies in the same industry are cheaper than CHSR, based on the Price/Earnings ratio.
CHSR's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.95.
Industry RankSector Rank
PE 30.43
Fwd PE N/A
CHSR.PA Price Earnings VS Forward Price EarningsCHSR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

60.47% of the companies in the same industry are more expensive than CHSR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.52
EV/EBITDA N/A
CHSR.PA Per share dataCHSR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHSR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHAUSSERIA

EPA:CHSR (5/6/2025, 7:00:00 PM)

7

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.36M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.43
Fwd PE N/A
P/S 1.64
P/FCF 12.52
P/OCF 10.94
P/B 0.69
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)0.23
EY3.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.56
FCFY7.99%
OCF(TTM)0.64
OCFY9.14%
SpS4.27
BVpS10.09
TBVpS8.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.91%
ROE 2.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 5.3%
GM 48.85%
FCFM 13.1%
ROA(3y)5.46%
ROA(5y)-3.88%
ROE(3y)6.53%
ROE(5y)-5.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.02%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y144.57%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.19%
GM growth 5Y3.5%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 247.15%
Current Ratio 16.39
Quick Ratio 13.59
Altman-Z 4.39
F-Score5
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-111.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.62%
Revenue growth 3Y-1.92%
Revenue growth 5Y-13.48%
Sales Q2Q%-6.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-106.26%
EBIT growth 3YN/A
EBIT growth 5Y111.59%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1233.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-394.75%
OCF growth 3YN/A
OCF growth 5YN/A